Drugs
Scientists want to study your at-home psychedelic mushroom experiences
Scientists are looking for people planning to trip on psychedelic mushrooms for a new study focused on people’s “real-world” experiences with psilocybin.
App brings psychedelic-assisted therapy into your home
The Field Trip app aims to help people get some of the benefits of psychedelic-assisted therapy outside the confines of a clinic.
One ayahuasca experience could have lasting effects on the brain
Researchers believe just one ayahuasca experience may be enough to have a lasting effect on the brain.
Afghan farmers use solar panels to grow food — and opium
Farmers in Afghanistan are taking advantage of cheap solar panels to power the water pumps they use to irrigate crops for food and opium production.
Microdosing marijuana can relieve chronic pain
Microdosing marijuana can relieve chronic pain without impairing a person’s ability to think clearly, according to a new study.
Psychedelic toad venom explained
5-MeO-DMT, a psychedelic found in toad venom, causes mushroom-intense trips that are over quick. Could it have more accessible therapeutic potential?
MDMA has long-lasting benefits as a PTSD treatment
The benefits of MDMA therapy as a PTSD treatment appear to last for at least a year, according to a newly published paper.
Psilocybin may impact your ego center
You’ve heard about “ego death” on magic mushrooms. New research suggests psilocybin curbs part of the brain that may tie in to ego.
Ketamine discovery may lead to new antidepressants
Researchers have uncovered new insights into how ketamine affects the brain, potentially illuminating the path to new antidepressants.
This company is using beer yeast to make psilocybin
Brewing the magic in Psilocybe cubensis is difficult at scale. One Danish company thinks beer yeast may be the answer.